Semaglutide 7mg
Price range: $210.00 through $720.00
| Quantity Value | Price | Quantity | Add To Cart |
|---|---|---|---|
| 10 Tablets | $210.00 |
|
|
| 20 Tablets | $400.00 |
|
|
| 30 Tablets | $570.00 |
|
|
| 40 Tablets | $720.00 |
|
SKU : N/A
Category : Weight Loss & Diabetic
Semaglutide 7mg is a GLP-1 receptor agonist used under medical supervision to help manage type 2 diabetes and support weight management.
Product Overview
Semaglutide 7mg is a prescription medicine primarily used to help manage type 2 diabetes and support weight management in individuals with certain medical conditions. It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists, which work by regulating blood sugar levels and appetite. Semaglutide 7mg is intended for use under the guidance of a healthcare professional and is not a substitute for lifestyle modifications such as diet and exercise.
How It Works
Semaglutide mimics the action of the naturally occurring hormone GLP-1 in the body. It stimulates insulin secretion from the pancreas when blood sugar levels are elevated, while also reducing the release of glucagon, a hormone that increases blood sugar. Additionally, Semaglutide slows gastric emptying, helping to control appetite and promote a feeling of fullness. Collectively, these mechanisms contribute to better blood sugar control and potential support in weight management.
Uses / Indications
Semaglutide 7mg is primarily indicated for:
-
Type 2 diabetes mellitus: As an adjunct to diet and exercise to improve glycemic control in adults.
-
Weight management: In individuals with obesity or overweight with associated comorbidities, when prescribed by a healthcare professional.
It is important to note that Semaglutide is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.
Composition
The active ingredient in this formulation is:
-
Semaglutide 7mg per dose (as per product specification)
Semaglutide 7mg is typically available as a pre-filled pen for subcutaneous injection. The formulation may also include excipients necessary to maintain stability and ensure proper administration.
Administration
Semaglutide is administered via subcutaneous injection, usually once weekly. Injection sites can include the abdomen, thigh, or upper arm, rotating locations to reduce local irritation. Medical supervision is essential, particularly during dose initiation and titration, to monitor blood sugar levels, potential side effects, and overall treatment response. Patients should receive proper training on injection technique from a healthcare provider.
Storage Instructions
-
Store Semaglutide 7mg pens in a refrigerator at 2°C to 8°C (36°F to 46°F) before first use.
-
Protect from light and do not freeze.
-
After the first use, pens may be kept at room temperature for a limited period (refer to manufacturer instructions) but should be discarded after the expiration of this period.
-
Keep out of reach of children and pets.
Important Information / Warning
-
Use only under the supervision of a healthcare professional.
-
Patients should report any symptoms of pancreatitis (e.g., severe abdominal pain), gallbladder issues, or significant gastrointestinal discomfort.
-
Individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid this medication.
-
Monitor for low blood sugar if used in combination with other antidiabetic agents.
-
Regular medical follow-up is essential to ensure safety and effectiveness.
For more detailed patient information, visit the FDA Semaglutide page.
| Pack Size |
10 Tablets ,20 Tablets ,30 Tablets ,40 Tablets |
|---|
